|
Back to Home » June 2020 News » MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon |
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ Sirolimus Drug Eluting Balloon |
June 30, 2020
NYON, Switzerland, June 30, 2020 /PRNewswire/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as...
Source URL: https://www.prnewswire.com:443/news-releases/medalliance-gains-ce-mark-approval-for-coronary-selution-slr-sirolimus-drug-eluting-balloon-301084367.html
|
|
|
|
